OCTRI KL2 Opportunity

The OCTRI Education Program is accepting letters of intent for the KL2 mentored career development award funded by NIH/NCATS. Faculty at OHSU, Portland State University, University of Oregon, and Oregon State University are eligible to apply.

Letter of Intent deadline: April 3, 2017

This opportunity supports the research training and career development of clinical and translational researchers for a maximum of two years.  All research proposed for this program must involve either clinical or translational research defined as involving human subjects or populations, or research that has direct application to human health.  The scholar is expected to apply for an independent career development award such as a K01, K07, K08, K22, K23, K25 or VA CDA, or an independent grant such as a R01 or equivalent.

OCTRI KL2 Scholar Support
  • At least 75% of the scholar's salary annually (not to exceed a cap of $100,000 plus OPE) per year for 2 years with satisfactory progress.  It is expected that the scholar's department will provide additional salary support if the overall salary exceeds $100,000.
  • A commitment of 75% effort for research and career development for up to 2 years.
  • $25,000 per year in research and travel funds.
  • Tuition-waiver costs for participation in the Human Investigations Program, including the Master of Clinical Research or Certificate in Human Investigation tracks. Courses or conferences outside of this program should be paid from research and travel funds.
  •  Participation in OCTRI-supported networking and mentoring activities such as offered by the OCTRI Scholars Program.
  • Priority support from OCTRI cores and services through voucher support.

Eligibility

Applicants must meet all the following requirements for the OCTRI KL2 award:

  • U.S. Citizen or Permanent Resident. Individuals with temporary or student visas are not eligible
  • Hold a clinical doctorate (e.g. MD/DO, DMD/DDS, DNS, PharmD, ND, OD, DC) or a research doctorate (PhD) and have a current or pending primary faculty appointment at OHSU, PSU, OSU or UO as an Assistant Professor level or equivalent. Clinicians must have completed specialty or subspecialty training by the time of the award.
  • No prior funding as principal investigator on an NIH research grant, including an R01 or any K series grant; or PI of a subproject of a program project grant (P01), center grant (P50, P60, U54); or other equivalent grant awards. Candidates are eligible if they have been supported by an NRSA grant (F or T) or an NIH small grant (R03 or R21).
  • KL2 applicants may not simultaneously submit or have pending an application for any other PHS mentored career development award (e.g. K07, K08, K22, or K23) that duplicates the provisions of the KL2 program.

Selection Criteria  

A KL2 selection committee will follow the model of the NIH peer review process for K awards. Selection criteria will focus on the strengths and potential of the candidate to become a leading multidisciplinary investigator judged in five major domains:
  • Potential of the Applicant: potential to conduct multidisciplinary research judging by research expertise and prior training; publications; prior participation in research.
  • Research Plan: Scientific value, potential clinical importance, and feasibility of the written multidisciplinary research plan
  • Training Plan: Quality, appropriateness, and composition of the multidisciplinary team of the proposed mentors; plan to gain didactic and other training.
  • Mentors: Tangible commitment and resources provided by the home department, including protected research time, and suitability of the available clinical and laboratory infrastructure and multidisciplinary team
  • Career Potential: Global assessment of the likelihood that the candidate will develop a career as an outstanding independent investigator and conduct research that will have an important impact on health. Individuals from underrepresented groups in research (women, ethnic minorities, and the disabled) are encouraged to apply. Special consideration will be given to individuals in disciplines traditionally under-represented in clinical and translational research.

Key Dates 2017:
Letter of Intent deadline
Notification of full application
Full application deadline
Presentation to selection committee
Notification of award
Expected start date
Monday, April 3
Friday, April 7
Monday, May 1
To be scheduled, May 22-May 25
Prior to July 1
July 1

Letter of Intent Submission 
The letter of intent and a biosketch in NIH format are required of all applicants and will be used to determine which applicants will be invited to submit a full application and schedule an oral presentation.    

Letters of intent must address the following areas and questions: 
  • Research aims for the proposed project 
  • Preliminary data, if any 
  •  Brief summary of the scientific plan
  • Career development goals, long term and short term 
  •  Brief details of educational and training plan
  • Proposed mentor team and primary mentor

Please refer to the complete RFA for specific information regarding page limitations and formatting for the letter of intent.  

Submit the letter of intent and a biosketch in NIH format via the online application linked below.  You will be asked to complete some demographic information before uploading documents.

Letter of Intent Submission

Complete RFA

The complete RFA includes additional details about the submission process, eligibility, and instructions.